Global Rapid Influenza Diagnostic Tests Market ANALYSE DE LA TAILLE ET DU PARTAGE - TENDANCES DE CROISSANCE ET PRÉVISIONS (2023 - 2030)
Global Rapid Influenza Diagnostic Tests Market is Segmented By Test Type (Rapid Molecular Assays, Rapid Immunoassay, and Others), By Influenza Type (Influenza Type A, Influenza Type B, Influenza Type C, and Others), By Specimen Type (Nasopharyngeal Swab, Nasal Swab, Throat Swab, and Others), By End User (Diagnostic Laboratories, Diagnostic Laboratories, Diagnostic Laboratories, and Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) . The report offers the value (in USD billion) for the above-mentioned segments.
Competitive overview of Global Rapid Influenza Diagnostic Tests Market
Parmi les principaux acteurs du marché des tests de diagnostic rapide de l'influenza figurent Quidel Corporation, Becton Dickinson, Thermo Fisher Scientific, Abbott Laboratories, F. Hoffmann-La Roche, DiaSorin, Luminex Corporation, Meridian Bioscience, GenMark Diagnostics, Sekisui Diagnostics et Virax Biolabs sont les principaux acteurs du marché.
Global Rapid Influenza Diagnostic Tests Market Leaders
- Société Quidel
- Becton Dickinson and Company
- Thermo Fisher Scientifique
- Laboratoires Abbott
- F.Hoffmann-La Roche Ltd.
Global Rapid Influenza Diagnostic Tests Market - Competitive Rivalry, 2023
Global Rapid Influenza Diagnostic Tests Market
(Dominated by major players)
(Highly competitive with lots of players.)